Nathalie Zeitouni

This early-stage study is testing a combination treatment for people with multiple basal cell skin cancers (BCCs). It combines a blue-light therapy applied to the skin with an oral drug called sonidegib. The goal is to see if this approach is safe and effective for patients who a…